Research, News & Discoveries
-
Mosquitoes have a mutual symbiotic relationship with malaria-causing pathogen
Cornelius Vanderbilt Professor of Biological Sciences Laurence J. Zwiebel is part of a team of researchers at Vanderbilt and the Johns Hopkins Malaria Research… Read MoreNov. 19, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, has conducted pioneering research on some of the most difficult drug discovery targets in cancer research. As a result of his lab’s discoveries, molecule-specific data has been made freely available for download to cancer researchers on the opensource platform opnMe.com, which… Read MoreNov. 15, 2021
-
Learn about the science of longevity with Vanderbilt experts in virtual event
Biomedical science has made huge strides in understanding the mechanics of human aging, and these discoveries have drastically affected how we work to prevent disease and increase longevity. On Tuesday, Nov. 30, 11 a.m.–noon CT, the School of Medicine Basic Sciences’ monthly virtual Lab-to-Table Conversation will bring aging research experts… Read MoreNov. 15, 2021
-
Former Chair of Biochemistry Michael Waterman dies
On Sunday, November 7, Michael Waterman, former chair of the Department of Biochemistry, passed away. Waterman was chair of biochemistry for 18 years and helped develop the department into a place where faculty could thrive. “Mike believed in empowering faculty,” David Cortez, current chair of the department, said. “He always… Read MoreNov. 12, 2021
-
New target identified for rapid antidepressant drugs
THE IDEA Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. Ege Kavalali (Vanderbilt University) Lisa Monteggia (John Russell/Vanderbilt University) The research was led by… Read MoreNov. 10, 2021
-
Finding a resistance to obesity
By Wendy Bindeman L-R: Sheila Collins, Ryan Ceddia A trans-institutional team that includes Professor of Medicine and Molecular Physiology and Biophysics Sheila Collins, first author and Collins lab postdoc Ryan Ceddia, and Johns Hopkins collaborators Dr. David Kass and Sumita Mishra recently published a study showing that mice lacking an… Read MoreNov. 9, 2021
-
Discovery shows how synapses are built and function in the nervous system
Nerve cells in the brain establish connections or synapses to form complex electrical circuits that keep people thinking and moving. Despite the importance of these synapses in mediating the flow of charged particles between neurons, not much is understood about how these connections are created. Sierra Palumbos David Miller Research… Read MoreNov. 8, 2021
-
Search committee announced to find next dean of School of Medicine Basic Sciences
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver has appointed a committee to conduct a national search for the next dean of the School of Medicine Basic Sciences. The committee includes faculty members, Vanderbilt University Medical Center leadership, a dean, an alumna and a current student. John Geer,… Read MoreNov. 8, 2021
-
Harrison Society researcher discovers key regulator of kidney cell structure
A molecular switch that regulates the cytoskeleton — the cellular equivalent of our skeleton — is required for the maintenance and integrity of the kidney collecting duct, Vanderbilt researchers have found. The discovery, reported in the Nov. 1 issue of the Journal of Cell Biology, could… Read MoreNov. 4, 2021
-
A new regulator of fat metabolism
By Wendy Bindeman Sheila Collins, professor of medicine. Sheila Collins, who is a professor of medicine and has a secondary appointment in molecular physiology and biophysics, first author Fubiao Shi, a postdoctoral fellow in the Collins lab, and colleagues have recently identified the transcription factor PPARγ as a novel regulator… Read MoreNov. 3, 2021